Category Archives: Pr Newswire

CANGZHOU, China, June 25, 2024 /PRNewswire/ — The year 2024 marked the 10th anniversary of Grand Canal’s UNESCO world heritage listing. The success of the application has revitalized the Grand Canal, which is a recognition of its historical value and an expectation for its future protection and development. Cangzhou, Hebei Province, has achieved fruitful results […]

A Science-Based Approach Will Determine if the Species is Truly ‘Endangered’ WASHINGTON, June 25, 2024 /PRNewswire/ — The National Association for Biomedical Research (NABR) commends the Union for the Conservation of Nature (IUCN)’s decision to reassess the ‘Endangered’ designation of long-tailed macaque monkeys (macaca fascicularis). “NABR is pleased that the IUCN will reassess its designation […]

Addressing the signal range challenge of many Beyond 5G networks, antenna and low-earth orbit satellite expert is facilitating adoption of 5G NTN in smaller private networks TOKYO and TAIPEI, June 25, 2024 /PRNewswire/ — As mobile communications speeds grow and Beyond 5G and 6G networks develop, signal range and coverage are growing challenges — and […]

SYDNEY, June 25, 2024 /PRNewswire/ — Emphasys Pty Ltd, a pioneer in SAP services and solutions, proudly announces its newly awarded Gold Partnership with Informatica, a leader in enterprise data management. This significant milestone underscores Emphasys’s commitment to delivering unparalleled data management solutions across Australia, the Asia Pacific, and Europe. Founded by a team of […]

JENA, Germany, June 24, 2024 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced today that GOHIBIC (vilobelimab) has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health […]

Helsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US Lugano, Switzerland – June 24, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus in supportive care, oncology and dermato-oncology, is pleased to announce […]

– Campaign to elevate experiences from the recurrent pericarditis community and provide resources to patients and caregivers – HAMILTON, Bermuda, June 24, 2024 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a commercial-stage biopharmaceutical company with a pipeline of immune-modulating assets designed to target a spectrum of cardiovascular and autoimmune diseases, today announced a […]

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare diseases, today announced the closing of its underwritten public offering of 11,250,000 shares of its common stock at a price to the public of $4.00 per share and, […]

SALT LAKE CITY, June 24, 2024 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that […]

LONDON, June 24, 2024 /PRNewswire/ — AMOLED technology is on a steady rise in the smartphone display market with shipments expected to surpass those of TFT LCDs = in 2024, according to Omdia’s latest Smartphone Display Market Tracker. 2023-2024 Smartphone display shipment and forecast by master technology With the full lifting of COVID-19 control measures in Q2 […]